Ambulero

About:

Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.

Website: https://www.ambulero.com/

Twitter/X: ambulero1

Top Investors: Orphinic Scientific

Description:

Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.

Total Funding Amount:

$5.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2019-01-01

Contact Email:

canderson(AT)ambulero.com

Founders:

Omaida Velazquez, Randy Berholtz, Robert Buchanan, Zhao-Jun Liu

Number of Employees:

1-10

Last Funding Date:

2021-01-25

IPO Status:

Private

Industries: